Home › Funds › a16z Capital Management, L.L.C. › ERAS

a16z Capital Management, L.L.C. position in ERAS

ERASCA INC · Health Care

a16z Capital Management, L.L.C. reported holding 2,862,500 shares of ERAS (ERASCA INC) in its Q2 2026 13F filing — a position valued at US$52.4M, representing 0.37% of its reported portfolio and ranking #8 among its reported holdings. a16z Capital Management, L.L.C. has disclosed ERAS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)2.86M sh
Reported value held$52.44M
Portfolio Weight0.37%
First reportedQ4 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How a16z Capital Management, L.L.C.'s ERAS position evolved

a16z Capital Management, L.L.C. first disclosed a stake in ERAS in Q4 2023 at 2,862,500 shares (US$6.1M). The position peaked in Q2 2026 at 2,862,500 shares, worth US$52.4M. Across 11 filings, a16z Capital Management, L.L.C. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,862,500 shares valued at US$52.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 2.86M $6.10M New
Q1 2024 2.86M $5.90M Hold
Q2 2024 2.86M $6.76M Hold
Q3 2024 2.86M $7.81M Hold
Q4 2024 2.86M $7.18M Hold
Q1 2025 2.86M $3.92M Hold
Q2 2025 2.86M $3.64M Hold
Q3 2025 2.86M $6.24M Hold
Q4 2025 2.86M $10.65M Hold
Q1 2026 2.86M $46.32M Hold
Q2 2026 2.86M $52.44M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has a16z Capital Management, L.L.C. held ERAS?

a16z Capital Management, L.L.C. has disclosed ERAS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is a16z Capital Management, L.L.C.'s current position in ERAS?

As of Q2 2026, a16z Capital Management, L.L.C. holds 2.86M shares of ERAS (ERASCA INC), valued at $52.44M, representing 0.37% of its reported portfolio and ranking #8.

Has a16z Capital Management, L.L.C. been buying or selling ERAS?

In the latest 13F filing (Q2 2026), a16z Capital Management, L.L.C. held unchanged its position in ERAS. The position peaked in Q2 2026 at 2.86M shares.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.